Filing Details
- Accession Number:
- 0001104659-14-018880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-12 18:37:38
- Reporting Period:
- 2014-03-11
- Filing Date:
- 2014-03-12
- Accepted Time:
- 2014-03-12 18:37:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1573553 | H.z. Seth Fischer | C/O Vivus, Inc. 351 East Evelyn Avenue Mountain View CA 94041 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-11 | 3,080 | $6.07 | 3,080 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.065 and $6.07 inclusive. The reporting person undertakes to provide to VIVUS, Inc., any security holder of VIVUS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form.
Billionaire Hedge Funds
